TRIM21 and acquired idiopathic inflammatory myopathy: MAAs were positive in 145/411 (35.3%) IIM patients and 77/269 (28.6%) controls (p = n.s.), of which anti-Ro52 was positive in 105/411 (25.5%) IIM patients and 56/269 (21%) controls (p = n.s.).